Institution May 05, 2021 Global rankings highlight Tec as university with social impact THE Impact Rankings 2021 highlight Tec de Monterrey as a world-leading university for social impact.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Institution April 21, 2021 Tec rector: universities more diverse and collaborative after COVID David Garza, rector and executive president of the Tec, shared his vision of education in the future, based on steps taken by universities during the COVID-19 crisis.
Institution April 19, 2021 David Garza at world summit: universities drive innovation David Garza, president of Tec de Monterrey, participated in the Times Higher Education conference through a virtual talk in which he reflected on innovation.
Art & Culture April 13, 2021 Mexican PrepaTec graduate wins BAFTA and is nominated for an Oscar Carlos Cortés, one of the Mexicans who won a BAFTA for their sound mixing work on the movie Sound of Metal, believes Mexican cinema has better talent.
Research March 26, 2021 Tec professor gives talk at MIT SCALE Latin America Conference A professor from Tecnológico de Monterrey gave a talk about the coexistence of “nanostores” in the retail ecosystem at the MIT SCALE Latin America Conference.
Institution March 16, 2021 Plan 2025: Tec de Monterrey outlines its plans for the future David Garza Salazar, rector and executive president of Tec de Monterrey, and the management team have presented plans and programs for the coming years.
Research March 04, 2021 American Chemical Society students at Tec create outreach site Students who are part of the Tec’s Monterrey Campus ACS Chapter, along with other student chapters in Latin America, have developed a platform for science communication.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
Institution February 15, 2021 Rector summarizes COVID-19 challenges faced by Tec David Garza, rector and executive president of Tec de Monterrey, presented the Tec’s board members with an overview of the pandemic-related challenges that the institution has had to face.
